Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Sarcopenia | Research article

Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting

Authors: Foon Yin Fung, Yi Ling Eileen Koh, Rahul Malhotra, Truls Ostbye, Ping Yein Lee, Sazlina Shariff Ghazali, Ngiap Chuan Tan

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

Sarcopenia is the age-related loss of muscle mass and function, which increases fall risks in older persons. Hyperglycemia relating to Type-2 Diabetes Mellitus (T2DM) is postulated to aggravate sarcopenia. This study aimed to determine the prevalence of sarcopenia among ambulatory community-dwelling older patients, aged 60–89 years, with T2DM in a primary care setting and to identify factors which mitigate sarcopenia.

Methods

A total of 387 patients were recruited from a public primary care clinic in Singapore. Data on their socio-demography, clinical and functional status, levels of physical activity (International Physical Activity Questionnaire) and frailty status was collected. The Asian Working Group for Sarcopenia (AWGS) criteria were used to define sarcopenia based on muscle mass, grip strength and gait speed.

Results

The study population comprised men (53%), Chinese (69%), mean age = 68.3 ± SD5.66 years, lived in public housing (90%), had hypertension (88%) and dyslipidemia (96%). Their mean muscle mass was 6.3 ± SD1.2 kg/m2; mean gait speed was 1.0 ± SD0.2 m/s and mean grip strength was 25.5 ± SD8.1 kg. Overall, 30% had pre-sarcopenia, 24% with sarcopenia and 4% with severe sarcopenia. Age (OR = 1.14; 95%CI = 1.09–1.20;p < 0.001), multi-morbidity (OR = 1.25;95%CI = 1.05–1.49;p = 0.011) diabetic nephropathy (OR = 2.50;95%CI = 1.35–5.13;p = 0.004), hip circumference (OR = 0.86;95%CI = 0.82–0.90;p < 0.001) and number of clinic visits in past 1 year (OR = 0.74; 95%CI = 0.59–0.92;p = 0.008) were associated with sarcopenia.

Conclusions

Using AWGS criteria, 58% of older patients with T2DM had pre-sarcopenia and sarcopenia. Age, diabetic nephropathy, hip circumference, multi-morbidity and fewer clinic visits, but not a recent single HBA1c reading, were significantly associated with sarcopenia among patients with T2DM. A longitudinal relationship between clinic visits and sarcopenia should be further evaluated.
(250 words)
Literature
1.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.CrossRef
2.
go back to reference Janssen I, Shepard DS, Katzmarzyk PTRR. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–5.CrossRef Janssen I, Shepard DS, Katzmarzyk PTRR. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80–5.CrossRef
3.
go back to reference Rizzoli R, Reginster J, Arnal J, Bautmans I. Europe PMC funders group quality of life in sarcopenia and frailty. Calcif Tissue Int. 2014;93:101–20.CrossRef Rizzoli R, Reginster J, Arnal J, Bautmans I. Europe PMC funders group quality of life in sarcopenia and frailty. Calcif Tissue Int. 2014;93:101–20.CrossRef
4.
go back to reference Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. 2014. Archives of public health. Arch Public Health. 2014;72(45):1–8. Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. 2014. Archives of public health. Arch Public Health. 2014;72(45):1–8.
5.
go back to reference Chen L, Liu L, Woo J, Assantachai P, Auyeung T, et al. Sarcopenia in Asia : consensus report of the Asian working group for sarcopenia. JAMDA. 2014;15:95–101.PubMed Chen L, Liu L, Woo J, Assantachai P, Auyeung T, et al. Sarcopenia in Asia : consensus report of the Asian working group for sarcopenia. JAMDA. 2014;15:95–101.PubMed
7.
go back to reference Kaushik S, Singh R, Cuervo AM. Autophagic pathways and metabolic stress. Diabetes Obes Metab. 2010;12:4–14.CrossRef Kaushik S, Singh R, Cuervo AM. Autophagic pathways and metabolic stress. Diabetes Obes Metab. 2010;12:4–14.CrossRef
8.
go back to reference Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006;147:4160–8.CrossRef Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006;147:4160–8.CrossRef
12.
go back to reference Norshafarina SK, Noor Ibrahim MS, Suzana S, Mohamad Hasnan A, Zahara M, Zaitun Y. Sarcopenia and its impact on health: do they have significant associations? Sains Malaysiana. 2013;42:1345–55. Norshafarina SK, Noor Ibrahim MS, Suzana S, Mohamad Hasnan A, Zahara M, Zaitun Y. Sarcopenia and its impact on health: do they have significant associations? Sains Malaysiana. 2013;42:1345–55.
13.
go back to reference Waist circumference and waist-hip ratio: Report of a WHO Expert Consultation Geneva, 8-11 December 2008. Waist circumference and waist-hip ratio: Report of a WHO Expert Consultation Geneva, 8-11 December 2008.
14.
go back to reference Therapists JMGSKVAS of H. Clinical assessment recommendations. 3rd ed. Mount Laurel: American Society of Hand Therapists; 2015. Therapists JMGSKVAS of H. Clinical assessment recommendations. 3rd ed. Mount Laurel: American Society of Hand Therapists; 2015.
17.
go back to reference Yoon JW, Ha Y, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging; 2016. p. 140–6. Yoon JW, Ha Y, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging; 2016. p. 140–6.
20.
go back to reference Tay L, Ding YY, Leung BP, Ismail NH, Yeo A, Yew S, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. 2015.CrossRef Tay L, Ding YY, Leung BP, Ismail NH, Yeo A, Yew S, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. 2015.CrossRef
21.
go back to reference Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, Mohamed ADA. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity; 2018. Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, Mohamed ADA. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity; 2018.
Metadata
Title
Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting
Authors
Foon Yin Fung
Yi Ling Eileen Koh
Rahul Malhotra
Truls Ostbye
Ping Yein Lee
Sazlina Shariff Ghazali
Ngiap Chuan Tan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1137-8

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine